Dr Boreham s Crucible: Breaking down the post-COVID market opportunity for Uscom stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.
Source: Unsplash/Louis Reed.
Businesses looking to encourage their workforce to get the COVID-19 jab should be aware of their privacy obligations and consider offering staff cash bonuses or paid leave.
A survey by the job site Indeed found that only 37% of employees agreed that their vaccination status should be made public in the workplace.
Jay Munro, head of career insights at Indeed, says most businesses aren’t legally permitted to demand their employees disclose whether they have been vaccinated.
“It’s important to note that it’s not mandated that employers can ask for vaccination status but what they can do is give ethical nudges,” Munro tells
Mayne Pharma Group Ltd(ASX: MYX) share price is shooting higher on Friday morning.
At the time of writing, the pharmaceutical company’s shares are up a massive 28% to 59 cents.
This latest gain means the Mayne Pharma share price is now up 69% since the start of the year.
Why is the Mayne Pharma share price charging higher?
Investors have been buying the company’s shares this morning following the release of a very positive announcement.
According to the release, the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) from Mayne Pharma and Mithra Pharmaceuticals for the novel combined oral contraceptive Nextstellis.